

Lupin Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 1.35 Cr
- Company Age 1 Year 10 Months
- Last Filing with ROC 31 Mar 2024
About Lupin Life Sciences
Lupin Life Sciences Limited (LLSL) is a Public Limited Indian Non-Government Company incorporated in India on 17 July 2023 (One year and ten months 18 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 1.35 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sunil Makharia, Rajeev Sibal, and Nilesh Gupta serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U86100MH2023PLC406793
- Company No.
406793
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Jul 2023
- Date of AGM
15 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Lupin Life Sciences?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Nilesh Gupta ![]() | Director | 17-Jul-2023 | Current |
Sunil Makharia ![]() | Director | 17-Jul-2023 | Current |
Rajeev Sibal ![]() | Director | 17-Jul-2023 | Current |
Financial Performance of Lupin Life Sciences.
Lupin Life Sciences Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Lupin Life Sciences?
Unlock access to Lupin Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Related Corporates (Common Directorship)
- Lupin Digital Health Limited
Sunil Makharia, Rajeev Sibal and 1 more are mutual person
- Lupin Limited
Nilesh Gupta is a mutual person
- Lupin Biologics Limited
Nilesh Gupta is a mutual person
- Lupin Diagnostics Limited
Sunil Makharia, Rajeev Sibal and 1 more are mutual person
- Lupin Investments Private Limited
Sunil Makharia and Nilesh Gupta are mutual person
- Polynova Industries Limited
Sunil Makharia and Nilesh Gupta are mutual person
Charges (Loans)

There are no open charges registered against the company as per our records.
How Many Employees Work at Lupin Life Sciences?
Lupin Life Sciences has a workforce of 0 employees as of Mar 19, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Lupin Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lupin Life Sciences's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Lupin Life Sciences
Recent activity within the organization
- Annual General Meeting
Lupin Life Sciences Limited last Annual general meeting of members was held on 15 Jul 2024 as per latest MCA records.
- Balance Sheet
Lupin Life Sciences Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
- Director Appointment
Sunil Makharia was appointed as a Director was appointed as a Director on 17 Jul 2023 & has been associated with this company since 1 year 10 months .
- Director Appointment
Rajeev Sibal was appointed as a Director was appointed as a Director on 17 Jul 2023 & has been associated with this company since 1 year 10 months .
- Director Appointment
Nilesh Deshbandhu Gupta was appointed as a Director was appointed as a Director on 17 Jul 2023 & has been associated with this company since 1 year 10 months .
- Company Incorporation
Lupin Life Sciences Limited was registered on 17 Jul 2023 with Roc Mumbai & aged 1 year 10 months as per MCA records.
Recent News, Updates & Announcement
- Lupin appoints Christoph Funke as new CTO.
Funke has previously worked in leadership roles at organisations such as Fresenius Kabi and Strides Pharma Science. In his leadership roles, Funke has managed large-scale technical operations and manufacturing networks across 27 sites in 19 countries, overseeing production value exceeding $ 2 billion and leading teams of over 12,500 employees, the press release said. Funke holds an engineering degree from South Westphalia University of Applied Sciences, Germany..
- Lupin gets USFDA nod to market generic drug to treat diabetes.
The product is a generic equivalent of AstraZeneca AB's Qtern tablets.
- FDA Warns that Tydemy May Have Reduced Effectiveness.
Lower levels of an active ingredient may result in unexpected pregnancies. .
- Facing regulator’s heat, Lupin shows urgency with quality control hire | Mint.
Whether Johnny Mikell will be given enough authority to steer the ship will be an important factor, say analysts.Resolving the issues soon will be crucial for the company, considering that further delays would make it more prominent on US FDA’s heat map.
Frequently asked questions
What is the Incorporation or founding date of Lupin Life Sciences Limited?
Lupin Life Sciences Limited was incorporated on 17 Jul 2023.
What is authorized share capital and paid-up capital of Lupin Life Sciences Limited?
The authorized share capital of Lupin Life Sciences Limited is ₹ 3.00 Cr and paid-up capital is ₹ 1.35 Cr.
Who are the current board members & directors of Lupin Life Sciences Limited?
Currently 3 directors are associated with Lupin Life Sciences Limited.
- Sunil Makharia
- Rajeev Sibal
- Nilesh Deshbandhu Gupta
What is the registered address of Lupin Life Sciences Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Lupin Life Sciences Limited is 3Rd Fl Kalpataru Inspire Off Western E. Highway India, Mumbai, Maharashtra, 400055.
What is the corporate identification number (CIN) and company number of Lupin Life Sciences Limited?
The corporate identification number (CIN) of Lupin Life Sciences Limited is U86100MH2023PLC406793 and the company number is 406793 as per Ministry of Corporate Affairs (MCA).
What is the official website of Lupin Life Sciences Limited?
The Official website of Lupin Life Sciences Limited is https://www.lupin.com
When was the last Balance Sheet of Lupin Life Sciences Limited filed with the ROC?
The most recent Balance Sheet for Lupin Life Sciences Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records